| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005002582A3 Trp-p8 active compounds and therapeutic treatment methods |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113356 Inhibitors of cathepsin S |
| 05/26/2005 | US20050113347 Novel antibacterial compounds: process for their preparation and pharmaceutical compositions containing them |
| 05/26/2005 | CA2544983A1 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1532124A1 Novel compounds |
| 05/25/2005 | EP1432682B1 Process for the preparation of repaglinide |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620419A 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 05/25/2005 | CN1618791A New synthesis method of alipirazole |
| 05/24/2005 | US6897220 Antiproliferative agents |
| 05/24/2005 | US6897218 Nitric oxide donors based on metallic centers |
| 05/24/2005 | CA2157289C Photochromic naphthopyran compounds |
| 05/19/2005 | WO2005044810A1 Glyt2 modulators |
| 05/19/2005 | WO2005044786A1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators |
| 05/19/2005 | WO2005044201A2 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/19/2005 | WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor |
| 05/19/2005 | WO2004092100A8 Indene derivatives as pharmaceutical agents |
| 05/19/2005 | WO2004028540A9 Anti-neurodegenerative agents |
| 05/19/2005 | US20050107637 Catalysts and method for the production of amines |
| 05/19/2005 | US20050107614 Reacting (S)-3-methyl-1-(2-piperidinophenyl)-1-butylamine with ethoxy-4-ethoxycarbonyl phenylacetic acid in the presence of pivaloyl chloride and a base, and removing the protecting group to obtain repaglinide |
| 05/19/2005 | US20050107607 Processes for preparing novel methylene blue derivative |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107398 benzamide compounds labeled with detectable radionuclides that selectively bind to cancer cells, used for medical diagnosis such as tomography |
| 05/19/2005 | US20050107397 Sulfonamide derivatives as d3-receptor agonists |
| 05/19/2005 | US20050107393 4-(diarylmethyl)-1-piperazinyl derivatives |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107354 Preventive or therapeutic agent for kidney disease |
| 05/19/2005 | US20050107309 Lowering elevated post-prandial blood glucose levels by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity; insulinotropic effects are enhanced |
| 05/19/2005 | US20050106712 Gelling agent or a precursor to a gelling agent, a microsphere immobilized on a substrate, containing a yellow azo-methine dye; protein microarray |
| 05/19/2005 | US20050104042 Process for the synthesis of amine ethers from secondary amino oxides |
| 05/19/2005 | DE10349059A1 Verfahren zur destillativen Auftrennung von Gemischen enthaltend Ethylenamine Method for the fractional distillation of mixtures containing ethylene amines |
| 05/19/2005 | DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | CA2545100A1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators |
| 05/19/2005 | CA2543166A1 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | EP1530470A1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1259484B1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 05/18/2005 | EP1202952B1 Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds |
| 05/18/2005 | CN1617865A Phenylalkynes |
| 05/18/2005 | CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/18/2005 | CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 05/18/2005 | CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1616440A Method for synthesizing 1-acetyl-4-(4-hydroxy pheny) piperazine |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1202098C Novel morpholone derivative and its prepn and use |
| 05/18/2005 | CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system |
| 05/17/2005 | US6894191 Reacting arylamine with aromatic halide in presence of catalyst and base |
| 05/17/2005 | US6894173 Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same |
| 05/17/2005 | US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus |
| 05/17/2005 | US6894059 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/17/2005 | US6894053 Potentiators of serotonin reuptake inhibitors; cyclohexane carboxylic acid-((1r)-1-cyclohexylmethyl-2-(4-(2-methoxy phenyl)-piperazin-1-yl)ethyl)amide derivatives |
| 05/17/2005 | US6894052 Serotonergic receptor antagonist |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/17/2005 | CA2278455C Amine heat stable salt neutralization having reduced solids |
| 05/17/2005 | CA2219796C Substituted benzenedithiol-metal complex |
| 05/17/2005 | CA2136597C Hydrazine derivatives and uses thereof |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/12/2005 | WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/12/2005 | WO2005042467A1 Quaternary amino-functional chalcones |
| 05/12/2005 | WO2005042464A1 Androgen receptor modulators |
| 05/12/2005 | WO2005042441A1 Method and apparatus for the use of [11c] carbon monixide in labeling synthesis by photo-initiated carbonylation |
| 05/12/2005 | WO2005023793A3 Direct synthesis of di-heteroatom containing cyclic organic compounds |
| 05/12/2005 | WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2 |
| 05/12/2005 | WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 05/12/2005 | WO2004048321A8 Phenylsulfoxide and phenylsulfone derivatives |
| 05/12/2005 | US20050101671 Compounds and compositions for delivering active agents |
| 05/12/2005 | US20050101645 P-(alpha-hydroxyhydrocarbylcarbonylamino)-substituted benzoic acid esters; reducing and/or slowing down the loss of head hair and/or body hair, or inducing and/or stimulating its growth |
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | US20050101610 Antiischemic agents; brain disorders; cardiovascular disorders; for the alleviation or treatment of symptoms due to neurodegenerative diseases and symptoms derived from diabetes, arteriosclerosis and inflammatory diseases ; for example, N-tert-butoxycarbonyl-4-[4-(4-fluorophenoxy)phenyl]-4-piperidinol |
| 05/12/2005 | CA2543345A1 Androgen receptor modulators |
| 05/12/2005 | CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | CN1615301A Dithiocarbamate derivatives and their use as antibacterial agents |
| 05/11/2005 | CN1615296A Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 05/11/2005 | CN1615295A Compounds for treatment of inflammation, diabetes and related disorders |
| 05/11/2005 | CN1615284A Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 05/11/2005 | CN1200703C Use of pentanoate derivant |
| 05/11/2005 | CN1200699C Anthracyclinone derivatives and their use in amyloidosis |
| 05/11/2005 | CN1200673C Antimicotic nail varnish composition |
| 05/10/2005 | US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 05/10/2005 | US6890949 Amino ceramide-like compounds and therapeutic methods of use |
| 05/10/2005 | US6890932 Anthranilic acid derivative |
| 05/10/2005 | US6890921 Selectively inhibit binding to alpha-1a adrenergic receptor; 1-(2-phthalimidoethyl)-4-(2-isopropyloxyphenyl)piperazine; N-(Ethyl-2-(2-iso-propyloxyphenyl)piperazin-4-yl))-(1'-(2-oxy -piperdinyl))acetamidemide |
| 05/10/2005 | US6890920 Therapeutic treatment of asthma, chronic obstructive pulmonary disease, rhinorrhea due to the common cold, rhinitis |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040142A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |